Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nature's Sunshine Products Share Holder Equity 2010-2024 | NATR

Nature's Sunshine Products share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  
Nature's Sunshine Products Annual Share Holder Equity
(Millions of US $)
2023 $160
2022 $147
2021 $161
2020 $157
2019 $129
2018 $121
2017 $120
2016 $132
2015 $136
2014 $129
2013 $105
2012 $116
2011 $87
2010 $68
2009 $57
Nature's Sunshine Products Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $163
2024-06-30 $156
2024-03-31 $160
2023-12-31 $160
2023-09-30 $152
2023-06-30 $149
2023-03-31 $147
2022-12-31 $147
2022-09-30 $142
2022-06-30 $144
2022-03-31 $150
2021-12-31 $161
2021-09-30 $148
2021-06-30 $147
2021-03-31 $141
2020-12-31 $157
2020-09-30 $148
2020-06-30 $139
2020-03-31 $133
2019-12-31 $129
2019-09-30 $127
2019-06-30 $125
2019-03-31 $122
2018-12-31 $121
2018-09-30 $123
2018-06-30 $122
2018-03-31 $121
2017-12-31 $120
2017-09-30 $136
2017-06-30 $134
2017-03-31 $134
2016-12-31 $132
2016-09-30 $142
2016-06-30 $139
2016-03-31 $137
2015-12-31 $136
2015-09-30 $135
2015-06-30 $134
2015-03-31 $133
2014-12-31 $129
2014-09-30 $137
2014-06-30 $118
2014-03-31 $115
2013-12-31 $105
2013-09-30 $105
2013-06-30 $123
2013-03-31 $119
2012-12-31 $116
2012-09-30 $112
2012-06-30 $103
2012-03-31 $96
2011-12-31 $87
2011-09-30 $80
2011-06-30 $84
2011-03-31 $76
2010-12-31 $68
2010-09-30 $67
2010-06-30 $64
2010-03-31 $63
2009-12-31 $57
2009-09-30 $53
2009-06-30 $51
2009-03-31 $49
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.277B $0.445B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.797B 29.55
Chugai Pharmaceutical (CHGCY) Japan $66.907B 26.06
Takeda Pharmaceutical (TAK) Japan $42.351B 8.81
Sandoz Group AG (SDZNY) Switzerland $20.614B 0.00
Merck (MKKGY) Germany $20.007B 17.92
Astellas Pharma (ALPMY) Japan $17.699B 16.30
United Therapeutics (UTHR) United States $16.641B 16.37
Summit Therapeutics (SMMT) United States $15.958B 0.00
Neurocrine Biosciences (NBIX) United States $15.256B 40.40
Shionogi (SGIOY) Japan $12.454B 12.48
Orion OYJ (ORINY) Finland $7.529B 21.17
Madrigal Pharmaceuticals (MDGL) United States $7.117B 0.00
Stevanato Group S.p.A (STVN) Italy $6.493B 42.04
Corcept Therapeutics (CORT) United States $6.447B 48.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.192B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.937B 7.84
Grifols, S.A (GRFS) Spain $4.813B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.652B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.858B 12.95
Recursion Pharmaceuticals (RXRX) United States $2.798B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.705B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $2.236B 0.00
Soleno Therapeutics (SLNO) United States $2.128B 0.00
Hypermarcas (HYPMY) Brazil $1.926B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.920B 0.00
Indivior (INDV) United States $1.675B 6.83
BioCryst Pharmaceuticals (BCRX) United States $1.661B 0.00
Evotec AG (EVO) Germany $1.495B 0.00
Guardian Pharmacy Services (GRDN) United States $1.413B 0.00
ARS Pharmaceuticals (SPRY) United States $1.392B 0.00
Dyne Therapeutics (DYN) United States $1.378B 0.00
Xencor (XNCR) United States $1.318B 0.00
Ardelyx (ARDX) United States $1.298B 0.00
Ocular Therapeutix (OCUL) United States $1.233B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.165B 0.00
Harrow (HROW) United States $1.152B 0.00
Collegium Pharmaceutical (COLL) United States $1.046B 5.71
Enliven Therapeutics (ELVN) United States $1.019B 0.00
Bioventus (BVS) United States $0.851B 26.90
Relay Therapeutics (RLAY) United States $0.750B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.738B 0.00
Cronos Group (CRON) Canada $0.719B 0.00
USANA Health Sciences (USNA) United States $0.662B 12.27
Verve Therapeutics (VERV) United States $0.652B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.595B 0.00
Xeris Biopharma Holdings (XERS) United States $0.544B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
Elite Pharmaceuticals (ELTP) United States $0.500B 0.00
Altimmune (ALT) United States $0.494B 0.00
Organogenesis (ORGO) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.474B 0.00
ProKidney (PROK) United States $0.467B 0.00
Savara (SVRA) United States $0.458B 0.00
OmniAb (OABI) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.447B 5.22
KalVista Pharmaceuticals (KALV) United States $0.433B 0.00
Oruka Therapeutics (ORKA) United States $0.422B 0.00
Zevra Therapeutics (ZVRA) United States $0.420B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.396B 160.64
Esperion Therapeutics (ESPR) United States $0.372B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Aldeyra Therapeutics (ALDX) United States $0.308B 0.00
Aquestive Therapeutics (AQST) United States $0.283B 0.00
CytoDyn (CYDY) United States $0.255B 0.00
Heron Therapeutics (HRTX) United States $0.254B 0.00
Avita Medical (RCEL) United States $0.246B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.237B 0.00
Larimar Therapeutics (LRMR) United States $0.237B 0.00
4D Molecular Therapeutics (FDMT) United States $0.231B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Inhibikase Therapeutics (IKT) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Acrivon Therapeutics (ACRV) United States $0.173B 0.00
Lexeo Therapeutics (LXEO) United States $0.172B 0.00
Lyell Immunopharma (LYEL) United States $0.169B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Nanobiotix S.A (NBTX) France $0.163B 0.00
Silence Therapeutics (SLN) United Kingdom $0.157B 0.00
Nektar Therapeutics (NKTR) United States $0.154B 0.00
Champions Oncology (CSBR) United States $0.153B 0.00
Telomir Pharmaceuticals (TELO) United States $0.134B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.117B 0.00
Inotiv (NOTV) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
ElectroCore (ECOR) United States $0.104B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
Protara Therapeutics (TARA) United States $0.093B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Journey Medical (DERM) United States $0.082B 0.00
AleAnna (ANNA) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.079B 20.75
Avalo Therapeutics (AVTX) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
AlloVir (ALVR) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 0.00
BioVie (BIVI) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mannatech (MTEX) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
BioLineRx (BLRX) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00